Tags

Type your tag names separated by a space and hit enter

Ferroptosis as a New Type of Cell Death and its Role in Cancer Treatment.
Klin Onkol. 2018 Winter; 31(Suppl 2):21-26.KO

Abstract

BACKGROUND

Ferroptosis is a recently discovered type of cell death. It is genetically, morphologically, and biochemically distinct from other types of programmed cell death, such as necrosis, apoptosis, and autophagy. The level of intracellular free iron and reactive oxygen species formation are important for ferroptosis activation, which can occur through either of two key inhibitory processes. The first one involves inhibition of cystine transfer into cells by the cystine/glutamate antiporter system (Xc-). Cystine serves as a precursor for the synthesis of glutathione, a major cellular antioxidant. The second one involves the inhibition of glutathione peroxidase 4, which protects cells from lipid peroxidation. Ferroptosis is associated with many metabolic disorders, including neurological diseases and cancer. Molecules involved in the activation of ferroptotic pathways are involved in protecting cells against stress conditions, and in the maintenance of nicotinamide adenine dinucleotide phosphate and glutathione levels, as well as iron homeostasis. Also important is the connection with autophagy, so called ferritinophagy, in which iron is released from lysosomes into the cytosol. Cascade reactions of free unstable iron atoms with other molecules result in the production of reactive oxygen species that initiate the cellular stress that triggers ferroptosis. In diseases such as cancer where cell death inducing mechanisms, including apoptosis, are usually suppressed by genetic changes, the induction of alternative pathways leading to cell death could provide an attractive treatment strategy.

CONCLUSION

In recent years, research into new antimetastatic drugs has focused on the activation of alternative cell death pathways that might overcome disturbed metabolic processes inside cancer cells or the chemotherapy resistance acquired in the course of routine treatment. A number of molecules have been found to induce ferroptosis in tumor cells, suggesting that they may offer new alternatives for anticancer treatment. Key words: cell death - cancer - autophagy - ferroptosis - ferritinophagy - cellular stress - ROS This work was supported by the projects GAČR 17-05838S, MEYS - NPS I - LO1413 and MH CZ- -DRO (MMCI, 00209805). The authors declare they have no potential conflicts of interest concerning drugs, products, or services used in the study. The Editorial Board declares that the manuscript met the ICMJE recommendation for biomedical papers. Accepted: 31. 8. 2018.

Authors

No affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

31023020

Citation

Skoupilová, Hana, et al. "Ferroptosis as a New Type of Cell Death and Its Role in Cancer Treatment." Klinicka Onkologie : Casopis Ceske a Slovenske Onkologicke Spolecnosti, vol. 31, no. Suppl 2, 2018, pp. 21-26.
Skoupilová H, Michalová E, Hrstka R. Ferroptosis as a New Type of Cell Death and its Role in Cancer Treatment. Klin Onkol. 2018;31(Suppl 2):21-26.
Skoupilová, H., Michalová, E., & Hrstka, R. (2018). Ferroptosis as a New Type of Cell Death and its Role in Cancer Treatment. Klinicka Onkologie : Casopis Ceske a Slovenske Onkologicke Spolecnosti, 31(Suppl 2), 21-26. https://doi.org/10.14735/amko20182S21
Skoupilová H, Michalová E, Hrstka R. Ferroptosis as a New Type of Cell Death and Its Role in Cancer Treatment. Klin Onkol. 2018;31(Suppl 2):21-26. PubMed PMID: 31023020.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Ferroptosis as a New Type of Cell Death and its Role in Cancer Treatment. AU - Skoupilová,Hana, AU - Michalová,Eva, AU - Hrstka,Roman, PY - 2019/4/27/entrez PY - 2018/1/1/pubmed PY - 2019/8/21/medline KW - 00209805). The authors declare they have no potential conflicts of interest concerning drugs KW - MEYS - NPS I - LO1413 and MH CZ- -DRO (MMCI KW - cell death - cancer - autophagy - ferroptosis - ferritinophagy - cellular stress - ROS This work was supported by the projects GAČR 17-05838S KW - or services used in the study. The Editorial Board declares that the manuscript met the ICMJE recommendation for biomedical papers. Accepted: 31. 8. 2018 KW - products SP - 21 EP - 26 JF - Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti JO - Klin Onkol VL - 31 IS - Suppl 2 N2 - BACKGROUND: Ferroptosis is a recently discovered type of cell death. It is genetically, morphologically, and biochemically distinct from other types of programmed cell death, such as necrosis, apoptosis, and autophagy. The level of intracellular free iron and reactive oxygen species formation are important for ferroptosis activation, which can occur through either of two key inhibitory processes. The first one involves inhibition of cystine transfer into cells by the cystine/glutamate antiporter system (Xc-). Cystine serves as a precursor for the synthesis of glutathione, a major cellular antioxidant. The second one involves the inhibition of glutathione peroxidase 4, which protects cells from lipid peroxidation. Ferroptosis is associated with many metabolic disorders, including neurological diseases and cancer. Molecules involved in the activation of ferroptotic pathways are involved in protecting cells against stress conditions, and in the maintenance of nicotinamide adenine dinucleotide phosphate and glutathione levels, as well as iron homeostasis. Also important is the connection with autophagy, so called ferritinophagy, in which iron is released from lysosomes into the cytosol. Cascade reactions of free unstable iron atoms with other molecules result in the production of reactive oxygen species that initiate the cellular stress that triggers ferroptosis. In diseases such as cancer where cell death inducing mechanisms, including apoptosis, are usually suppressed by genetic changes, the induction of alternative pathways leading to cell death could provide an attractive treatment strategy. CONCLUSION: In recent years, research into new antimetastatic drugs has focused on the activation of alternative cell death pathways that might overcome disturbed metabolic processes inside cancer cells or the chemotherapy resistance acquired in the course of routine treatment. A number of molecules have been found to induce ferroptosis in tumor cells, suggesting that they may offer new alternatives for anticancer treatment. Key words: cell death - cancer - autophagy - ferroptosis - ferritinophagy - cellular stress - ROS This work was supported by the projects GAČR 17-05838S, MEYS - NPS I - LO1413 and MH CZ- -DRO (MMCI, 00209805). The authors declare they have no potential conflicts of interest concerning drugs, products, or services used in the study. The Editorial Board declares that the manuscript met the ICMJE recommendation for biomedical papers. Accepted: 31. 8. 2018. SN - 1802-5307 UR - https://www.unboundmedicine.com/medline/citation/31023020/Ferroptosis_as_a_New_Type_of_Cell_Death_and_its_Role_in_Cancer_Treatment_ L2 - https://www.prolekare.cz/linkout/105919 DB - PRIME DP - Unbound Medicine ER -
Try the Free App:
Prime PubMed app for iOS iPhone iPad
Prime PubMed app for Android
Prime PubMed is provided
free to individuals by:
Unbound Medicine.